ONECUT2 and hepatocellular carcinoma: In hepatocellular carcinoma, the knockout of OC2 using the CRISPR/Cas9 system not only significantly inhibits the proliferation and angiogenesis of hepatocellular carcinoma cells but also markedly promotes apoptosis.